RTM Healthcare Group

🎉 Happy New Year 2025 from The RTM Healthcare Group! 🎉 As we step into a promising new year, we at RTM Healthcare Group express our sincere gratitude to our partners, clients, and team members for their continued trust and collaboration. Together, let’s make 2025 a year of growth and meaningful achievements in the healthcare and pharmaceutical industry. Wishing you and your families health, happiness, and success in the year ahead. 💜

🎅🎄 Merry Christmas to all! May this season of giving and gratitude bring warmth to your heart and success to your ventures. 🌟✨ #MerryChristmas #SeasonOfHope #RTMHealthcareGroup #EnhancingAccess

From tradition to innovation, Qatar's incredible journey of unity, resilience and visionary progress shines on the world stage. Celebrating the spirit of Qatar today and every day! Happy National Qatar Day! #RTMHealthcareDay #Qatar #EnhancingAccess

This Universal Health Coverage Day, at the RTM Healthcare Group, we reaffirm our commitment with health through innovation and strategic partnerships, we’re breaking barriers and paving the way for equitable access to life-saving solutions. Because health is not just a service, it’s a universal right. Together, we’re #EnhancingAccess and building a healthier, brighter future for all. 💜  #RTMHealthcare #UniversalHealthCoverageDay #HealthMatters #EnhancingAccess

#CPHIIndia2024 was a success! Thank you to everyone who met us, we look forward to future collaborations! 🙌✨ Raman Wattamwar Mrudula Wattamwar Sanket Gavhane Sandeep khandeshe Gopal Chavan B P. #CPHI #AtTheHeartOfPharma #RTMHealthcareGroup #EnhancingAccess

The biosimilars market is experiencing remarkable growth, with projections indicating a significant expansion from $29.4 billion in 2023 to $66.9 billion by 2028, with a CAGR of 17.8% (Markets and Markets, 2023). This is being driven by an increasing demand for cost-effective treatments, the expiration of patents on major biologics, rising prevalence of chronic diseases, and regulatory support (Delveinsight, 2021). At RTM Healthcare Group, we share the vision of making advanced treatments accessible across regions; in line with the growth of the biosimilars market, we were present at Biosimilars LATAM - Mexico 2024, with the participation of our CEO Raman Wattamwar, who spoke about the growth opportunities of this industry and the access of biosimilars globally, especially in emerging markets, and the Impact of Biosimilar Licenses on Pharmaceutical Innovation. Video retrieved from: https://lnkd.in/e-ZTEch4 JackLeckerman #Biosimilars #Pharmaceuticals #HealthcareInnovation #BiosimilarsLatamMexico2024 #EnhancingAccess

⏳ Just one day to go until CPHI India 2024, and we can’t wait to dive into three days of networking, learning, and innovation! Join us as we connect with global healthcare leaders. 🌟 To arrange a meeting, please contact Mr. Sanket Gavhane, at +91 84848 07342 or at sanketg@rtmhealthcaregroup.com. #PharmaIndustry #RTMHealthcare #CPHIIndia2024 #EnhancingAccess

Let's meet at #CPHI India 2024! Join us in exploring innovative solutions for the pharmaceutical industry, and let's discuss how we can drive growth in emerging markets 📈 💼 See you #AtTheHeartOfPharma 💜 #RTMHealthcareGroup #CPHIIndia2024 #PharmaIndustry #EnhancingAccess

On Antimicrobial Resistance Awareness Week, we call for the rational use of medicines 💊🦠. Together, we can fight AMR. Education and prevention can make the difference! #AMRWeek #FightAMR #PreventResistance #EnhancingAccess

Today is World Pancreatic Cancer Day, a date to reflect on the importance of early diagnosis and continued research in the fight against this disease. Every year, thousands of people face this challenge, but together we can raise awareness and provide better treatment options 💜